May 2020;22:5-9
Disclosure of interest: Nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.06 - IMAGING - Hyperacute P2080 - ESOC25-1542 CT PERFUSION IN CEREBELLAR STROKE: EVALUATION OF PERFUSION ABNORMALITIES Edoardo Ricci 1 , Giovanni Furlanis 1 , Milo Ajevi 2 , Emanuele Vincis 1 , Gabriele Prandin 1 , Laura Manicinelli 1 , Federica Palacino 1 , Quagliotto Magda 1 , Paola Caruso 1 , Marcello Naccarato 1 , Paolo Manganotti 1 1 Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste - ASUGI, University of Trieste, Trieste, Italy, 2 Department of Engineering and Architecture, University of Trieste, Trieste, Italy Background and Aims: Acute cerebellar ischemic stroke (ACIS) is characterized by often non-specific clinical signs such as vertigo or postural instability, with neuroimaging playing a pivotal role in assessment in the emergency setting
Human clinical trials of systemic GHK-Cu administration remain extremely limited, representing a critical knowledge gap requiring investigation before systemic therapeutic applications can be appropriately evaluated
If it goes their way, compounds now sold online in vials stamped for research only could move onto pharmacy shelves
NAD is an enzyme naturally produced by the body that plays a central role in how cells generate energy
Die Pharmazie 61 , 341342 (2006)
